---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-026337"
form_type: "8-K"
ticker: null
cik: "0001169987"
company_name: "HTG MOLECULAR DIAGNOSTICS, INC"
filed_at: "2023-06-05T23:59:59+00:00"
generated_at: "2026-06-14T07:10:46.606107+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 1.0
calibrated_materiality_score: 1.0
confidence: "high"
source: SEC EDGAR
---

# HTG Molecular Diagnostics files Chapter 11; debt of $2.7M accelerated; CCO terminated

## Summary
- Filed Chapter 11 petition (Case No. 23-10732) on June 5, 2023 in Delaware Bankruptcy Court.
- Filing triggered default accelerating $2,687,255 loan from Silicon Valley Bank/First-Citizens.
- Terminated SVP & Chief Commercial Officer Byron T. Lawson effective June 2, 2023; $23K consulting.
- Company to operate as debtor-in-possession while court considers first-day motions.

## SEC filing metadata
- accession: 0000950170-23-026337
- form_type: 8-K
- cik: 0001169987
- company_name: HTG MOLECULAR DIAGNOSTICS, INC
- filed_at: 2023-06-05T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 1.0
- calibrated_materiality_score: 1.0
- confidence: high
- sec_items: 1.03, 2.04, 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1169987/000095017023026337/0000950170-23-026337-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1169987/000095017023026337/htgm-20230601.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-026337
- JSON: https://secwatch.observer/filing/0000950170-23-026337.json
- Plain text: https://secwatch.observer/filing/0000950170-23-026337.txt

## Key facts
- Debt Financings
  HTG MOLECULAR DIAGNOSTICS, INC faced acceleration on credit facility of $2,687,255 with Silicon Valley Bank, N.A., a division of First-Citizens Bank and Trust Company.
  - Instrument: credit facility
  - Principal: $2,687,255
  - Counterparty: Silicon Valley Bank, N.A., a division of First-Citizens Bank and Trust Company
  - Event: acceleration
  source text: The filing of the Case constituted an event of default that accelerated all of the Company’s obligations under the Company’s Loan and Security Agreement, dated June 24, 2020, as amended, with Silicon Valley Bank, N.A., a division of First-Citizens Bank and Trust Company (“Loan Agreement”), comprising an outstanding principal amount of $2,687,255, together with accrued interest and all applicable fees and other financial obligations.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1169987/000095017023026337/0000950170-23-026337-index.htm
- Distress & Bankruptcy
  HTG MOLECULAR DIAGNOSTICS, INC entered chapter 11 in United States Bankruptcy Court for the District of Delaware (petition 2023-06-05).
  - Proceeding: chapter 11
  - Court: United States Bankruptcy Court for the District of Delaware
  - Petition: 2023-06-05
  source text: On June 5, 2023 (the “Petition Date”), HTG Molecular Diagnostics, Inc. (the “Company”) filed a voluntary petition (Case No. 23-10732) for relief under Chapter 11 of the United States Bankruptcy Code (the “Code”) in the United States Bankruptcy Court for the District of Delaware
  evidence_url: https://www.sec.gov/Archives/edgar/data/1169987/000095017023026337/0000950170-23-026337-index.htm
- Executive change
  Byron T. Lawson was terminated as Senior Vice President and Chief Commercial Officer at HTG MOLECULAR DIAGNOSTICS, INC.
  - Action: terminated
  - Role: Senior Vice President and Chief Commercial Officer
  source text: On June 1, 2023, the Company notified Byron T. Lawson, Senior Vice President and Chief Commercial Officer of the Company, of his termination of employment, effective June 2, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1169987/000095017023026337/0000950170-23-026337-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.